Mohammad Azab's Net Worth

$2.93 Million

Estimate Recalculated Sep 16, 2025 06:18PM EST

Who is Mohammad Azab

Mohammad Azab has an estimated net worth of $2.93 Million. This is based on reported shares across multiple companies, which include Xenon Pharmaceuticals Inc., DURECT CORP, QLT INC/BC, LISATA THERAPEUTICS, INC., Astex Pharmaceuticals, Inc, and CHEMOKINE THERAPEUTICS CORP.

SEC CIK

Mohammad Azab's CIK is 0001309653

Past Insider Trading and Trends

2022 was Mohammad Azab's most active year for acquiring shares with 13 total transactions. Mohammad Azab's most active month to acquire stocks was the month of April. 2013 was Mohammad Azab's most active year for disposing of shares, totalling 6 transactions. Mohammad Azab's most active month to dispose stocks was the month of September. 2022 saw Mohammad Azab paying a total of $152,081.99 for 155,286 shares, this is the most they've acquired in one year. In 2013 Mohammad Azab cashed out on 1,108,753 shares for a total of $0.00, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Xenon Pharmaceuticals Inc.

Investor
Updated Dec 20, 2023
Dec 19
18.48KJun 02
Dec 12
18.00KJun 28
Showing 5 results

DURECT CORP

Investor
Updated Jun 23, 2023
5.50KJun 21
55.00KJun 15
May 24
May 16 - May 17
27.50KJun 15
70.00KJan 04
Showing 7 results

QLT INC/BC

Exec VP-R&D, CMO
Updated May 25, 2005
May 24
30.00KMar 09
200.00
Showing 3 results

LISATA THERAPEUTICS, INC.

Investor
Updated Jan 11, 2024
58.68KJan 09
39.20KJan 09
Sep 15
Showing 4 results

Astex Pharmaceuticals, Inc

Chief Medical Officer
Updated Oct 16, 2013
Oct 11
300.00KDec 06
200.00KMar 07
280.00KMar 24
60.00KMar 11
260.00KJul 21
Showing 7 results

CHEMOKINE THERAPEUTICS CORP

Investor
Updated Feb 13, 2006
Showing 1 results